Suchergebnisse - "Shah, Nina"

PubPharm (352)

1

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

enthalten in: Blood cancer journal | 2024

von Callander, N. | Silbermann, R. | Kaufman, J. | +33

2

Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone : Patient-reported outcomes from GRIFFIN

enthalten in: American journal of hematology | 2024

von Silbermann, R. | Laubach, J. | Kaufman, J. | +23

3

CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy

enthalten in: Blood advances | 2024

von Ledergor, G. | Fan, Z. | Wu, K. | +16

4

Salvage Therapies including Retreatment with BCMA-directed Approaches Following BCMA CAR-T Relapses for Multiple Myeloma

enthalten in: Blood advances | 2024

von Reyes, K. | Liu, Y. | Huang, C. | +8

5

Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis

enthalten in: Bone marrow transplantation | 2024

von Malek, A. | Al-Juhaishi, T. | Milton, D. | +27

6

Randomized phase 2 study of digital life coaching during transplantation for myeloma

enthalten in: Bone marrow transplantation | 2023

von Banerjee, R. | Huang, C. | Ryan, C. | +10

7

Harm reduction in undergraduate and graduate medical education : a systematic scoping review

enthalten in: BMC medical education | 2023

von Smith, K. | Shah, N. | Adamczyk, A. | +2

8

Harm reduction in undergraduate and graduate medical education: a systematic scoping review

enthalten in: BMC medical education | 2023

von Smith, K. | Shah, N. | Adamczyk, A. | +2

9

Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma : BMT CTN 1401

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Chung, D. | Shah, N. | Wu, J. | +36

CommentIn: Clin Cancer Res. 2023 Dec 1;29(23):4703-4705. - PMID 37733765

10

Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancer

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Chaitesipaseut, L. | Shah, N. | Truong, T. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]